Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

Archer Daniels & Vland Tie Up For Better Animal Feed Products

Published 01/18/2018, 10:03 PM
Updated 07/09/2023, 06:31 AM
ADM
-
SYY
-
UNFI
-
NOMD
-

Archer Daniels Midland Company (NYSE:ADM) has signed a joint development agreement with Qingdao Vland Biotech Group Co., Ltd. — the leading biotech company in China. The move is expected to help develop new enzymes for animal feed applications. This will aid in improving animal nutrition and health. Also, both the companies should be able to commercialize the products that will be developed under this agreement.

Per the agreement, these companies will exchange enzyme-producing strains to develop feed enzymes. To support activities under the agreement, Archer Daniels plans to open a new U.S. enzyme research and development center in California. This new facility will be in addition to the company’s existing research center in Decatur, IL. Further, Vland’s plans to upgrade its Qingdao lab with modern facilities, in order to carry out research and development under the joint agreement.

Notably, this deal is a significant move toward enhancing Archer Daniels’ capacities in bioactives, enzymes as well as novel ingredients for the food, pharmaceutical and animal feed space. This will bolster the company’s foothold in the rapidly-growing enzymes business.

Archer Daniels’ Performance

Archer Daniels has been struggling against a tough operating environment in the Agricultural industry due to fluctuating commodity prices and oversupply. This has been largely denting the company’s top and bottom lines while keeping margins strained. Apparently, its sales lagged the Zacks Consensus Estimate for more than three years now, alongside delivering negative earnings surprise in eight of the last 10 quarters.

Consequently, this Zacks Rank #5 (Strong Sell) company’s shares have lost 6.7% in a year against the Consumer Staples sector’s growth of 14.6%.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .



We expect strategic deals and agreements like the one mentioned above might provide cushion and help fuel the company’s growth.

Looking for Solid Picks in the Same Space, Check These

Some better-ranked stocks in the broader Consumer Staples sector include Sysco Corporation (NYSE:SYY) , Nomad Foods Limited (NYSE:NOMD) and United Natural Foods, Inc. (NASDAQ:UNFI) .

Sysco with a long-term earnings growth rate of 9% has delivered an average positive earnings surprise of 2.6% in the trailing four quarters. Also, the stock sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Nomad Foods carries a Zacks Rank #2 (Buy) and has pulled off an average positive earnings surprise of 26.1% in the last reported quarter.

United Natural Foods, a Zacks Rank #2 stock, has a long-term earnings growth rate of 6.2%. Also, the company has delivered an average positive earnings surprise of 2.3% in the trailing four quarters.

Will You Make a Fortune on the Shift to Electric Cars?

Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.

With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.

It's not the one you think.

See This Ticker Free >>



Sysco Corporation (SYY): Free Stock Analysis Report
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

United Natural Foods, Inc. (UNFI): Free Stock Analysis Report

Archer-Daniels-Midland Company (ADM): Free Stock Analysis Report

Nomad Foods Limited (NOMD): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.